Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-02-02 to 2022-02-24
Current total value of award: $3837
Description: 4556181161!ZOLADEX 3.6 MG IMPLANT SYRNS